Synribo
PHONETIC PRONUNCIATION: Synribo
Description
Synribo is a medication that is mainly used in the treatment of chronic myeloid leukemia. The drug has been approved for use in adults with chronic-phase or accelerated-phase chronic myeloid leukemia who have previously been treated with at least two tyrosine kinase inhibitors. This article will provide an overview of the uses, dosage, demographic, side effects, interactions, and generic options of Synribo. Uses of Synribo Synribo works by inhibiting the activity of a protein known as BCR-ABL, which is produced by certain cancer cells. The protein plays a crucial role in the growth and division of these cancer cells. By inhibiting this protein, Synribo can slow down or halt the growth of cancer cells, preventing them from spreading to other parts of the body. Dosage of Synribo The dosage of Synribo will vary depending on the individual's medical condition and response to treatment. The medication is usually given as an injection under the skin (subcutaneously) once daily for 14 consecutive days, followed by a 14-day treatment-free period. This cycle is repeated every 28 days until the disease progresses, the patient experiences unacceptable toxicity, or the patient achieves a hematologic response (decrease or normalization of the blood cell counts). Demographic of Synribo Synribo has been approved for use in adults with chronic-phase or accelerated-phase chronic myeloid leukemia who have previously been treated with at least two tyrosine kinase inhibitors. The medication is not recommended for use in children or in patients with severe liver or kidney dysfunction. Side Effects of Synribo Like all medications, Synribo can cause side effects. The most common side effects of Synribo include fatigue, nausea, vomiting, diarrhea, abdominal pain, fever, headache, anemia, and low platelet count. Some patients may also experience more severe side effects, such as bleeding, infection, liver toxicity, and heart problems. Patients should report any unusual symptoms to their healthcare providers promptly. Interactions of Synribo Patients taking Synribo should inform their healthcare providers about any other medications they are taking, including over-the-counter medications, vitamins, and supplements. Some medications may interact with Synribo, increasing the risk of side effects or reducing the medication's effectiveness. Patients should also avoid live vaccines while taking Synribo. Generic Options of Synribo There are currently no generic versions of Synribo available in the United States. The medication is only available as a brand-name drug. Conclusion Synribo is a medication that is effective in treating chronic myeloid leukemia in adults who have previously been treated with at least two tyrosine kinase inhibitors. The medication works by inhibiting the activity of a protein that is produced by cancer cells, slowing down or halting the growth of cancer cells. Patients taking Synribo may experience side effects, and the medication may interact with other medications. There are currently no generic versions of Synribo available in the United States. Patients should discuss the risks and benefits of taking Synribo with their healthcare providers to determine if it is the right treatment option for their medical condition.
Faq for Synribo
Synribo is a prescription medication used to treat certain types of leukemia in adults.
Synribo works by inhibiting the growth of cancer cells, thereby slowing down the progression of leukemia.
Common side effects of Synribo may include nausea, vomiting, diarrhea, fatigue, headache, fever, rash, and cough.
Synribo is administered as an injection under the skin (subcutaneous injection) twice daily for 5 consecutive days, followed by a 9-day rest period. This 28-day cycle is repeated as directed by the healthcare provider.
The duration of treatment with Synribo varies depending on the individual's response and the severity of their condition. It is best to follow your healthcare provider's instructions on the duration of treatment.
It is important to inform your healthcare provider about all the medications, supplements, and herbal products you are taking, as some may interact with Synribo. Your healthcare provider can provide guidance on the use of concomitant medications.
Synribo's coverage by insurance varies depending on the specific insurance plan. It is recommended to contact your insurance provider to determine the coverage and any associated costs.
If you miss a dose of Synribo, contact your healthcare provider as soon as possible for guidance on the next steps. Do not administer a double dose to make up for a missed one.
Synribo may harm an unborn baby, so it is generally not recommended for use during pregnancy. It is important to discuss with your healthcare provider if you are pregnant or planning to become pregnant. The use of Synribo while breastfeeding should also be discussed with a healthcare provider, as it is unknown whether the drug passes into breast milk.
Precautions with Synribo include regular blood tests to monitor the response to treatment and to check for any potential side effects. It is also important to practice proper hygiene and follow appropriate precautions to reduce the risk of infection.